Tag:

#Childrens Health

Health

ADHD medications stimulate alertness, motivation

by Chief Editor
written by Chief Editor

January 27, 2026

ADHD Treatment: A Shift in Understanding and Future Directions

For decades, the prevailing wisdom held that stimulant medications for Attention-Deficit/Hyperactivity Disorder (ADHD) worked by directly boosting attention spans. However, groundbreaking research is challenging this long-held belief. A recent study, published in Cell, reveals that these medications primarily impact brain networks responsible for wakefulness and reward, rather than attention itself. This discovery isn’t dismissing the effectiveness of stimulants, but rather reshaping our understanding of how they work – and opening doors to potentially more nuanced and effective treatment strategies.

Beyond Attention: The Role of Wakefulness and Reward

The research, leveraging data from the extensive NIH’s Adolescent Brain Cognitive Development (ABCD) study, analyzed brain scans of nearly 5,800 children aged 8-11. Researchers found that stimulants like Ritalin and Adderall activated brain regions associated with alertness and motivation. Interestingly, the areas directly linked to sustained attention remained largely unchanged. Further experiments with adults confirmed these findings, suggesting a consistent neurological effect across age groups.

“This isn’t to say stimulants don’t help with focus,” explains Dr. Benjamin Kay, lead author of the study. “It’s that they achieve this indirectly. By increasing arousal and activating reward pathways, they make tasks – even those typically perceived as boring or challenging – more engaging. This is why they can be so effective in a classroom setting.”

Sleep and ADHD: A Powerful Connection

Perhaps the most intriguing aspect of the study is the overlap between the effects of stimulants and those of adequate sleep. The brain activity patterns observed in children taking stimulants closely resembled those seen in well-rested individuals. This suggests a powerful interplay between sleep and ADHD, and raises the possibility that addressing sleep deficiencies could be a crucial component of treatment.

Consider the case of 10-year-old Leo, diagnosed with ADHD. His parents noticed his symptoms worsened significantly during periods of poor sleep. After implementing a consistent bedtime routine and addressing underlying sleep issues, Leo’s need for medication decreased, and his academic performance improved. This isn’t an isolated incident; the study showed stimulants were most effective in children who were already sleep-deprived.

The Future of ADHD Treatment: Personalized Approaches

This new understanding is paving the way for a more personalized approach to ADHD treatment. Instead of solely relying on medication, clinicians are increasingly focusing on a holistic strategy that incorporates:

  • Sleep Hygiene Assessments: Identifying and addressing sleep disorders or poor sleep habits.
  • Behavioral Therapy: Teaching coping mechanisms and strategies for managing impulsivity and hyperactivity.
  • Nutritional Interventions: Exploring the role of diet in brain health and ADHD symptoms.
  • Neurofeedback: A technique that trains individuals to self-regulate their brain activity.

The rise of wearable technology and advanced brain imaging techniques will further refine these personalized approaches. Imagine a future where a simple wearable device can monitor a child’s sleep patterns, brain activity, and response to different stimuli, allowing doctors to tailor treatment plans with unprecedented precision.

The Potential of Non-Stimulant Medications

While stimulants remain the most commonly prescribed medication for ADHD, research into non-stimulant alternatives is gaining momentum. These medications, such as atomoxetine (Strattera) and guanfacine (Intuniv), work through different neurological pathways and may offer a viable option for individuals who don’t respond well to stimulants or experience undesirable side effects. The new understanding of ADHD’s neurological basis could accelerate the development of even more targeted non-stimulant therapies.

Pro Tip:

Don’t underestimate the power of routine. Consistent mealtimes, bedtimes, and dedicated study periods can significantly improve focus and reduce ADHD symptoms, even alongside medication.

Did you know?

Approximately 5% of children and 2.5% of adults are diagnosed with ADHD, making it one of the most common neurodevelopmental disorders.

FAQ

  • Do stimulants still have a role in ADHD treatment? Yes, stimulants remain effective for many individuals, but understanding their mechanism of action allows for more informed treatment decisions.
  • Is ADHD solely a childhood disorder? No, ADHD often persists into adulthood, although symptoms may change over time.
  • Can lifestyle changes replace medication? For some individuals, lifestyle changes like improved sleep and diet can significantly reduce symptoms. However, medication may still be necessary for others.
  • What is neurofeedback? Neurofeedback is a type of biofeedback that uses real-time displays of brain activity to teach self-regulation of brain function.

The evolving understanding of ADHD is a testament to the power of ongoing research. By moving beyond simplistic explanations and embracing a more nuanced view of the brain, we can unlock new possibilities for effective treatment and improved quality of life for individuals living with this complex condition.

Want to learn more about ADHD and available resources? Visit the CDC’s ADHD page or explore the resources at CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder).

0 comments
0 FacebookTwitterPinterestEmail
Health

Newborn screening tests become political issue in the U.K.

by Chief Editor
written by Chief Editor

The Future of Newborn Screening: A Race to Detect and Treat More

The debate surrounding newborn screening is heating up. While the concept – testing newborns for treatable conditions – is universally accepted, the extent of that screening is becoming a critical point of contention. The UK’s comparatively limited panel of 10 diseases, contrasted with the US’s recommended 36 (and growing), highlights a global divergence in priorities and approaches. But this isn’t just a matter of national healthcare policy; it’s a rapidly evolving field driven by scientific breakthroughs and the promise of personalized medicine.

The Expanding Landscape of Treatable Diseases

For decades, newborn screening focused on relatively common, well-understood genetic disorders like phenylketonuria (PKU) and congenital hypothyroidism. These conditions, if left untreated, lead to severe developmental problems. Early detection and intervention dramatically improved outcomes. However, advances in genomics and therapies are now opening doors to screening for a far wider range of conditions.

The key driver is the rise of gene therapies. As STAT News reported in 2021, these therapies, while not cures, can significantly alter the course of devastating genetic diseases. But their effectiveness is often maximized when administered before irreversible damage occurs – making early detection through expanded newborn screening crucial. Conditions like Spinal Muscular Atrophy (SMA), once a death sentence for infants, are now treatable with gene therapy, but the window for optimal intervention is narrow.

The Cost-Benefit Analysis: A Complex Equation

Expanding newborn screening isn’t without its challenges. Cost is a major factor. Screening for more diseases requires more sophisticated technology, trained personnel, and follow-up care. There’s also the issue of false positives – results that indicate a potential problem but are ultimately incorrect. False positives can cause significant anxiety for parents and lead to unnecessary testing.

Furthermore, the ethical implications of identifying predispositions to diseases that may not manifest for years, or even decades, are being debated. How do you counsel parents about uncertain futures? What are the psychological impacts of knowing a child carries a gene associated with a late-onset condition? These are questions that healthcare systems and ethicists are grappling with.

The Role of Artificial Intelligence and Big Data

The future of newborn screening will likely be heavily influenced by artificial intelligence (AI) and big data analytics. AI algorithms can analyze vast genomic datasets to identify patterns and predict which newborns are at highest risk for specific conditions. This could lead to more targeted and efficient screening programs.

“We’re moving towards a future where newborn screening isn’t just about testing for a fixed list of diseases,” explains Dr. Emily Carter, a geneticist at Boston Children’s Hospital. “It’s about using genomic information to personalize screening based on a baby’s individual risk profile.” This personalized approach could dramatically improve the accuracy and effectiveness of screening, while also reducing the number of false positives.

Did you know? Whole-genome sequencing (WGS) – mapping a baby’s entire genome – is becoming increasingly affordable. While not yet standard practice, WGS could eventually provide a comprehensive picture of a newborn’s genetic health, allowing for the detection of a much wider range of conditions.

Drugmaker Influence and the Push for Wider Screening

The pharmaceutical industry has a vested interest in expanded newborn screening. The development of gene therapies and other specialized treatments creates a strong incentive for drugmakers to ensure their products reach the patients who need them. Wider screening increases the pool of potential patients, boosting revenue and justifying the high costs of drug development.

However, this creates a potential conflict of interest. Critics argue that drugmakers may lobby for the inclusion of diseases on screening panels even if the clinical benefits of early detection are uncertain. Transparency and independent oversight are crucial to ensure that screening decisions are based on sound medical evidence, not commercial considerations.

Future Trends to Watch

  • Expansion of Tandem Mass Spectrometry: This technology allows for the simultaneous screening of multiple metabolic disorders from a single blood sample, making it more efficient and cost-effective.
  • RNA Sequencing for Early Cancer Detection: Research is underway to explore the use of RNA sequencing to detect early signs of childhood cancers.
  • Pharmacogenomic Screening: Identifying genetic variations that affect a baby’s response to certain medications, allowing for personalized drug dosing.
  • Global Standardization Efforts: Organizations like the World Health Organization (WHO) are working to develop guidelines for newborn screening, aiming to reduce disparities in access to care.

FAQ

Q: What is the difference between screening and diagnosis?
A: Screening identifies babies who may have a condition, while diagnosis confirms the presence of the condition through further testing.

Q: What happens if a newborn screens positive for a disease?
A: Further testing is conducted to confirm the diagnosis. If confirmed, treatment is initiated as soon as possible.

Q: Is newborn screening mandatory?
A: In most countries, newborn screening is mandatory, although parents may be able to opt out in some cases.

Q: How often is the list of screened diseases updated?
A: The frequency varies by country. Updates typically occur when new treatments become available or when the benefits of early detection are clearly demonstrated.

Pro Tip: Talk to your pediatrician about newborn screening and ask any questions you may have. Understanding the process can help alleviate anxiety and ensure your baby receives the best possible care.

Want to learn more about genetic testing and newborn health? Explore the National Human Genome Research Institute website for comprehensive information and resources.

Share your thoughts on the future of newborn screening in the comments below! What conditions do you think should be prioritized for inclusion on screening panels?

0 comments
0 FacebookTwitterPinterestEmail
Health

RFK Jr.’s ‘Make America Healthy Again’ Movement: Why Ignoring It Isn’t the Answer

by Chief Editor
written by Chief Editor

The ‘Make America Healthy Again’ Movement: Beyond the Headlines and Into the Future

The recent shifts in CDC vaccine schedules, spurred by allies of Robert F. Kennedy Jr., weren’t an isolated event. They were a symptom of a much larger, evolving phenomenon: the rise of the “Make America Healthy Again” (MAHA) movement. While often dismissed as fringe, MAHA is gaining traction, representing a significant and increasingly influential force in American health perspectives. Ignoring it, or simply labeling it as misinformation, is no longer a viable strategy.

Understanding the Roots of Distrust

For decades, public health messaging has relied heavily on authority and scientific consensus. However, a confluence of factors – the opioid crisis, perceived failures in the COVID-19 response, and a growing sense of alienation from institutions – has eroded that trust. As highlighted by the podcast “Why Should I Trust You?”, the core of MAHA isn’t necessarily anti-science, but rather a deep-seated skepticism towards established systems.

This skepticism isn’t limited to vaccines. It extends to dietary guidelines, pharmaceutical interventions, and even conventional medical practices. A KFF poll from October 2025 revealed that 4 in 10 parents now identify as MAHA supporters, demonstrating the breadth of its appeal. This isn’t a fleeting trend; it’s a fundamental shift in how a substantial portion of the population views health and wellness.

The Expanding MAHA Ecosystem

MAHA isn’t a monolithic entity. It’s a diverse ecosystem encompassing various viewpoints, from those genuinely concerned about vaccine safety to individuals seeking alternative health solutions. This diversity is reflected in the movement’s growing presence across multiple platforms.

Influencer Impact: Podcasters like Joe Rogan, Shawn Ryan, and Andrew Huberman wield immense influence, often discussing health topics through a MAHA-aligned lens. Rogan’s continued focus on COVID-era censorship and “Big Pharma” profits, for example, resonates with a large audience.

Corporate Co-option: Even mainstream businesses are taking notice. Sweetgreen’s collaboration with MAHA-aligned doctor Mark Hyman to redesign menu items signals a growing recognition of the movement’s consumer base. This isn’t necessarily an endorsement of MAHA’s core tenets, but a pragmatic response to market demand.

Legislative Push: A Politico analysis last summer revealed hundreds of MAHA-friendly bills introduced in state legislatures, targeting issues like ultraprocessed foods, pesticides, vaccine requirements, and raw milk access. This demonstrates a concerted effort to translate MAHA principles into policy.

Future Trends: Where is MAHA Headed?

Several key trends suggest MAHA’s influence will continue to grow in the coming years:

  • Personalized Health & Biohacking: A growing emphasis on personalized medicine, genetic testing, and “biohacking” – optimizing health through diet, supplements, and technology – aligns with MAHA’s focus on individual agency and self-reliance.
  • Regenerative Agriculture & Food Systems: MAHA’s interest in regenerative agriculture and sustainable food systems will likely intensify, driven by concerns about pesticide use and the environmental impact of industrial farming.
  • Decentralized Healthcare: Expect increased demand for alternative healthcare models, such as functional medicine, naturopathy, and telehealth, offering more individualized and holistic approaches.
  • Increased Political Activism: MAHA supporters will likely become more politically engaged, advocating for policies that align with their values and challenging established healthcare norms.
  • Focus on Mental Wellbeing: A growing awareness of the link between mental and physical health will likely see MAHA expand its focus to include holistic mental wellness practices.

Did you know? The number of parents refusing vitamin K for their newborns is increasing, reflecting a growing distrust in standard medical protocols.

The Role of Shared Pain and Building Bridges

The “Why Should I Trust You?” podcast highlights a crucial element often overlooked in discussions about MAHA: shared pain. Many supporters have experienced personal tragedies – addiction, chronic illness, or perceived failures of the medical system – that fuel their skepticism.

Building bridges requires acknowledging this pain and engaging in respectful dialogue, even when disagreements are profound. The podcast’s success in connecting MAHA organizers with researchers, leading to an NIH grant for studying drinking water safety in East Palestine, Ohio, demonstrates the potential for collaboration.

Pro Tip: When engaging with individuals holding MAHA beliefs, focus on understanding their personal experiences and motivations rather than immediately attempting to debunk their claims.

Navigating the Future: A Call for Nuance

The rise of MAHA presents a challenge to public health institutions. Simply dismissing the movement as misinformation is counterproductive. A more nuanced approach is needed – one that acknowledges the legitimate concerns driving its growth, fosters open dialogue, and seeks common ground.

This requires a willingness to listen, to empathize, and to address the underlying issues of trust and alienation. It also requires a commitment to transparency, accountability, and a more patient-centered approach to healthcare.

FAQ

Q: Is MAHA an anti-vaccine movement?
A: While some elements within MAHA are strongly anti-vaccine, the movement is more diverse. Many supporters are skeptical of certain vaccines or vaccine schedules, but not necessarily opposed to all vaccines.

Q: Is MAHA a dangerous movement?
A: MAHA’s potential dangers lie in the spread of misinformation and the rejection of evidence-based medical practices. However, dismissing the movement outright ignores the legitimate concerns of its supporters.

Q: What can public health officials do to address MAHA?
A: Public health officials should focus on building trust, engaging in open dialogue, addressing the root causes of distrust, and promoting transparency in healthcare.

Q: Where can I learn more about the “Why Should I Trust You?” podcast?
A: You can find the podcast on Apple Podcasts: Why Should I Trust You.

What are your thoughts on the evolving landscape of health and wellness? Share your perspective in the comments below! Explore our other articles on public health trends and alternative medicine to deepen your understanding.

0 comments
0 FacebookTwitterPinterestEmail
Health

Kennedy’s Vaccine Schedule: Why Shared Decision-Making Could Boost Trust

by Chief Editor
written by Chief Editor

The Shifting Sands of Vaccine Consent: A Future of Shared Decision-Making?

The recent controversy surrounding the revised U.S. pediatric vaccine schedule, spearheaded by Health and Human Services Secretary Robert F. Kennedy Jr., isn’t just about which vaccines are recommended. It’s a flashpoint in a much larger debate: who truly decides what gets injected into our children’s bodies? While the scientific community largely agrees on the safety and efficacy of established vaccines, a growing chorus – and increasingly, policy changes – are pushing for a more collaborative approach to vaccination, one centered on shared clinical decision-making (SCDM).

Beyond Presumption: The Erosion of “Just Do It” Medicine

For decades, the standard advice to pediatricians has been to adopt a “presumptive” approach: state the vaccines a child needs as if parental acceptance is a given. The CDC’s guidance, until recently, explicitly encouraged this. But this approach, while effective in maximizing uptake, has arguably chipped away at the foundational principle of informed consent. A 2022 study published in Academic Pediatrics found that only 40% of parents reported receiving a balanced discussion about vaccine risks and benefits from their child’s pediatrician. This isn’t necessarily malicious; it’s a consequence of a system prioritizing population immunity over individual autonomy.

The move to SCDM for six vaccines isn’t necessarily about questioning their safety. It’s about acknowledging that even with robust evidence, parents deserve a genuine conversation, a space to voice concerns, and a collaborative approach to risk-benefit assessment. This shift reflects a broader trend in healthcare towards patient-centered care, where individuals are empowered to actively participate in their medical decisions.

The Rise of Vaccine Hesitancy and the Need for Trust

Vaccine hesitancy isn’t a monolithic phenomenon. It’s a spectrum of concerns, ranging from genuine fear of side effects to distrust in pharmaceutical companies and government institutions. The COVID-19 pandemic dramatically highlighted this, with misinformation spreading rapidly online and eroding public trust. According to a Gallup poll conducted in late 2023, confidence in Americans’ healthcare system is at a historic low.

Simply doubling down on the scientific evidence, while crucial, isn’t enough to address this distrust. A more effective strategy involves acknowledging parental concerns, providing transparent information, and fostering a relationship built on mutual respect. This is where SCDM becomes invaluable. It transforms the conversation from a directive to a dialogue, potentially building trust and increasing vaccine acceptance in the long run.

Technology’s Role: Personalized Risk Assessments and Digital Tools

The future of vaccine decision-making will likely be heavily influenced by technology. We’re already seeing the development of personalized risk assessment tools that can help parents and clinicians weigh the benefits and risks of vaccination based on individual health factors and circumstances. These tools, powered by artificial intelligence and machine learning, could provide tailored recommendations and address specific concerns.

Furthermore, telehealth platforms can facilitate more in-depth conversations about vaccines, allowing parents to connect with healthcare professionals remotely and receive personalized guidance. Digital vaccine records and reminder systems can also improve adherence and ensure that children receive the recommended immunizations.

The Legal Landscape: Informed Consent and Parental Rights

The legal framework surrounding vaccine mandates and informed consent is complex and varies by state. However, the principle of informed consent – the right of a patient to understand the risks and benefits of a medical intervention before agreeing to it – is universally recognized. As SCDM becomes more prevalent, legal challenges related to vaccine mandates are likely to increase, forcing courts to grapple with the balance between individual rights and public health concerns.

Recent court cases, such as those challenging school vaccine requirements, demonstrate a growing willingness to scrutinize the legal basis for mandatory vaccination policies. This trend suggests that healthcare providers and public health officials must be prepared to defend their recommendations with clear, evidence-based reasoning and a commitment to respecting parental autonomy.

Navigating the Future: A Proactive Approach

The shift towards SCDM isn’t a retreat from science; it’s an evolution in how we communicate and engage with the public about vaccines. To navigate this changing landscape effectively, healthcare professionals need to:

  • Embrace active listening: Truly hear and acknowledge parental concerns without judgment.
  • Provide clear and concise information: Avoid jargon and present the evidence in a way that is easy to understand.
  • Utilize decision aids: Employ tools that help parents weigh the risks and benefits of vaccination.
  • Foster trust: Build a strong relationship with patients based on honesty, transparency, and respect.

The future of vaccination isn’t about forcing compliance; it’s about building confidence through collaboration and empowering individuals to make informed decisions about their health.

FAQ: Vaccine Consent and Shared Decision-Making

Q: Does shared decision-making mean vaccines are optional?
A: No. It means parents and healthcare providers discuss the risks and benefits together, but vaccines remain strongly recommended based on scientific evidence.

Q: Will SCDM lower vaccination rates?
A: Potentially in the short term. However, building trust through open communication may lead to higher rates long-term.

Q: What resources are available to help me have a vaccine conversation with my doctor?
A: The CDC (https://www.cdc.gov/vaccines-children/hcp/conversation-tips/index.html) and Immunization Action Coalition (https://www.immunize.org/) offer valuable resources.

Pro Tip: Prepare a list of questions before your appointment to ensure you address all your concerns with your healthcare provider.

What are your thoughts on the evolving landscape of vaccine consent? Share your perspective in the comments below. Explore our other articles on public health and vaccine safety for more in-depth information. Subscribe to our newsletter for the latest updates and insights.

0 comments
0 FacebookTwitterPinterestEmail
Health

ByHeart Formula Botulism: Milk Powder Linked to Outbreak

by Chief Editor
written by Chief Editor

The ByHeart Botulism Outbreak: A Turning Point for Infant Formula Safety?

The recent outbreak of infant botulism linked to ByHeart formula, potentially traced back to contaminated powdered whole milk, isn’t just a single incident. It’s a stark warning and a potential catalyst for significant changes in how infant formula is produced, tested, and regulated. While the FDA investigation continues, the implications for the $4.3 billion US infant formula market are substantial.

The Powdered Milk Problem: A Vulnerability Exposed

The reliance on powdered ingredients, particularly whole milk powder, introduces inherent risks. Powdered milk, due to its low moisture content, can harbor Clostridium botulinum spores – the bacteria responsible for botulism – if not handled meticulously. These spores are ubiquitous in the environment, making complete elimination incredibly challenging. The ByHeart case highlights that even suppliers considered reputable can be sources of contamination. This isn’t a new concern; outbreaks linked to powdered formula have occurred before, but the scale of the ByHeart incident is unprecedented, as noted by food safety experts.

Did you know? Clostridium botulinum thrives in low-oxygen environments, making sealed formula containers a potential breeding ground if spores are present.

Beyond ByHeart: Systemic Issues and the Need for Mandatory Testing

While the FDA assures the public there’s no indication of a broader problem, the incident raises serious questions about the adequacy of current testing protocols. Currently, testing for Clostridium botulinum in infant formula isn’t universally mandated. Some companies, like ByHeart, conduct testing, but the frequency and scope vary. Sarah Sorscher of the Center for Science in the Public Interest rightly points out the need for required testing of both raw materials and finished products. This isn’t just about detecting the bacteria; it’s about proactively preventing contamination at the source.

The European Union, for example, has stricter regulations regarding microbiological testing of infant formula ingredients. A 2023 report by the European Food Safety Authority (EFSA) emphasized the importance of robust risk assessments and control measures throughout the entire production chain. The US could learn from this approach.

The Rise of Transparency and Consumer Demand

The ByHeart outbreak has fueled a growing demand for transparency from formula manufacturers. Parents are no longer satisfied with vague assurances of quality; they want detailed information about ingredient sourcing, testing procedures, and potential risks. This shift in consumer expectations is driving companies to invest in more sophisticated traceability systems and to openly communicate their safety protocols.

Pro Tip: When choosing infant formula, look for brands that provide detailed information about their quality control processes on their website. Don’t hesitate to contact the company directly with questions.

Traceability Technologies: From Farm to Formula

Blockchain technology and advanced data analytics are emerging as powerful tools for enhancing traceability in the food supply chain. These technologies can track ingredients from their origin – the farm – through every stage of processing, manufacturing, and distribution. This level of transparency allows for rapid identification and isolation of contaminated products in the event of an outbreak. Companies like IBM Food Trust are already implementing blockchain solutions for various food products, and its application to infant formula is a logical next step.

Legal Ramifications and Corporate Responsibility

As Bill Marler, a leading food safety lawyer, emphasizes, the responsibility for product safety ultimately lies with the manufacturer, even if the contamination originates with a supplier. The ByHeart case is likely to result in significant legal challenges, potentially setting a precedent for future product liability claims. This underscores the importance of robust supplier vetting and ongoing monitoring of ingredient quality.

The Future of Infant Formula: Innovation and Safety

Looking ahead, several trends are likely to shape the future of infant formula:

  • Enhanced Testing Protocols: Expect stricter regulations and mandatory testing for Clostridium botulinum and other pathogens.
  • Advanced Traceability Systems: Blockchain and data analytics will become increasingly prevalent.
  • Alternative Processing Methods: Exploring alternative processing techniques that minimize the risk of spore formation.
  • Focus on Ingredient Sourcing: Greater emphasis on sourcing ingredients from trusted and rigorously vetted suppliers.
  • Direct-to-Consumer Models: Increased adoption of direct-to-consumer models, allowing manufacturers to maintain greater control over the supply chain and communicate directly with parents.

FAQ: Infant Formula Safety

  • What is infant botulism? A serious illness caused by toxins produced by the Clostridium botulinum bacteria.
  • How can I protect my baby from botulism? Choose reputable formula brands, follow preparation instructions carefully, and report any unusual symptoms to your pediatrician.
  • Is powdered formula safe? Powdered formula can be safe, but it carries a higher risk of contamination than liquid formula.
  • What should I do if I suspect my baby has botulism? Seek immediate medical attention.

The ByHeart outbreak serves as a critical reminder that infant formula safety is paramount. The industry, regulators, and consumers must work together to ensure that every can of formula is safe for the most vulnerable among us.

Want to learn more? Explore our articles on food safety regulations and infant nutrition for further insights.

Share your thoughts on this important issue in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

US Rotavirus Vaccine Downgrade: An Epidemiologist’s Warning

by Chief Editor
written by Chief Editor

The Unraveling of U.S. Vaccine Leadership: A Dangerous Trend?

The recent decision by the Department of Health and Human Services to remove rotavirus from the list of universally recommended childhood vaccines isn’t an isolated incident. It’s a symptom of a growing trend – a questioning of established vaccine protocols and a potential erosion of U.S. leadership in global public health. As an epidemiologist who’s witnessed the devastating impact of preventable diseases firsthand, and as a parent who experienced the fear of a child battling a severe infection, this shift is deeply concerning.

Beyond Rotavirus: A Wider Pattern of Vaccine Hesitancy

The rotavirus decision, alongside changes to recommendations for other vaccines, reflects a broader climate of vaccine hesitancy fueled by misinformation and, increasingly, by policy decisions that appear to prioritize individual choice over collective immunity. While parental autonomy is important, it shouldn’t come at the expense of proven public health interventions. We’re seeing similar debates erupt around the HPV vaccine, the MMR vaccine, and even influenza vaccination, often driven by unsubstantiated safety concerns and a distrust of scientific consensus.

This isn’t just a U.S. phenomenon, but the U.S. historically played a crucial role in setting global standards. The CDC’s expertise and data were often the foundation for World Health Organization (WHO) recommendations. Now, with the U.S. deviating from established norms, other nations may feel emboldened to follow suit, potentially reversing decades of progress in disease eradication.

The Data Doesn’t Lie: The Impact of Rotavirus Vaccination

Before the introduction of the rotavirus vaccine, over 50,000 U.S. children were hospitalized annually due to this highly contagious virus. Following widespread vaccination, hospitalizations plummeted by 80-90%. This isn’t just about preventing deaths – although nearly 450,000 children globally still die each year from diarrheal diseases, with rotavirus accounting for almost half. It’s about reducing suffering, easing the burden on healthcare systems, and allowing parents to avoid the agonizing experience of watching their child battle severe dehydration and illness.

The argument that the rotavirus vaccine carries a small risk of intussusception (a bowel obstruction) is often cited. However, rigorous studies have consistently shown that the benefits of vaccination far outweigh the risks. The very fact that this rare side effect was identified is a testament to the robust vaccine safety surveillance systems in place – systems that are now, arguably, being undermined by a lack of consistent support.

The Role of Misinformation and Political Influence

The spread of misinformation online plays a significant role in fueling vaccine hesitancy. Social media algorithms often prioritize sensationalized content over evidence-based information, creating echo chambers where false narratives thrive. This is compounded by increasing political interference in public health decisions, as evidenced by recent appointments to key positions within the HHS. The report justifying the changes to the vaccine schedule, authored by newly appointed officials, was criticized for selectively presenting data and downplaying the benefits of vaccination.

Pro Tip: Always verify health information with reputable sources like the CDC (https://www.cdc.gov/), WHO (https://www.who.int/), and your healthcare provider.

Future Implications: A Cascade Effect?

The downgrading of the rotavirus vaccine recommendation could have a cascading effect. If the U.S. continues to deviate from established vaccine guidelines, it risks losing its credibility as a global health leader. This could lead to:

  • Reduced vaccine uptake in other countries, particularly those that rely on U.S. expertise.
  • Resurgence of preventable diseases, leading to increased morbidity and mortality.
  • Erosion of public trust in public health institutions.
  • Increased healthcare costs associated with treating preventable illnesses.

The shift towards “shared clinical decision-making” – while sounding reasonable – is likely to result in fewer children being vaccinated, particularly those from underserved communities who may have limited access to healthcare. Clinicians, lacking clear guidance, may be hesitant to strongly recommend vaccines, leading to lower vaccination rates.

What Can Be Done?

Reversing this trend requires a multi-pronged approach:

  • Strengthening public health funding: Investing in robust vaccine surveillance systems and public health infrastructure.
  • Combating misinformation: Developing effective strategies to counter false narratives about vaccines.
  • Promoting science literacy: Educating the public about the importance of vaccination and the scientific process.
  • Protecting the independence of public health agencies: Ensuring that public health decisions are based on scientific evidence, not political considerations.

The health of our children – and the health of the world – depends on it.

Frequently Asked Questions (FAQ)

  • Is the rotavirus vaccine safe? Yes, the rotavirus vaccine is generally safe and effective. While a rare link to intussusception has been identified, the benefits of vaccination far outweigh the risks.
  • Why is the U.S. changing its vaccine recommendations? The HHS cites safety concerns and a comparison to vaccine schedules in other countries, but this rationale has been widely criticized as being based on flawed data and motivated reasoning.
  • What is herd immunity? Herd immunity occurs when a large percentage of the population is immune to a disease, making it difficult for the disease to spread and protecting those who are not immune.
  • Where can I find reliable information about vaccines? The CDC (https://www.cdc.gov/vaccines/) and WHO (https://www.who.int/vaccines) are excellent sources of information.

Did you know? Rotavirus is the leading cause of severe diarrheal illness in infants and young children worldwide.

What are your thoughts on the changing landscape of vaccine recommendations? Share your perspective in the comments below. Explore our other articles on public health and vaccine safety to learn more.

0 comments
0 FacebookTwitterPinterestEmail
Health

Vaccine Injury Program Advisor Removed From Federal Committee

by Chief Editor
written by Chief Editor

Shifting Sands: What a Vaccine Advisory Committee Member’s Removal Signals

The recent, unexpected removal of Veronica McNally, an attorney and director of trial advocacy at Michigan State University, from the Advisory Commission on Childhood Vaccinations (ACCV) has sent ripples through the world of vaccine safety and injury compensation. While the Department of Health and Human Services (HHS) offered a standard “grateful for your contributions” message, the premature end to McNally’s term – slated to run through December 2027 – raises questions about the future direction of the federal program designed to assist those who experience adverse effects from vaccines.

The Role of the ACCV: A Critical Review Process

The ACCV plays a vital, though often unseen, role in the National Vaccine Injury Compensation Program (VICP). Established in the late 1980s, the VICP was created to shield vaccine manufacturers from liability while ensuring individuals injured by vaccines have a no-fault system for compensation. The ACCV advises the HHS Secretary on petitions filed under the VICP, reviewing medical evidence and legal arguments to determine eligibility for benefits. This process is crucial for maintaining public trust in vaccination programs.

Historically, the VICP has faced criticism from both sides. Some argue the program is too restrictive, making it difficult for legitimate claims to be approved. Others contend it’s overly generous, potentially discouraging vaccine development. Changes to the ACCV’s composition could significantly impact the balance of these considerations.

Why McNally’s Removal Matters: A Potential Shift in Perspective

Details surrounding McNally’s removal remain scarce, fueling speculation. Her background as an attorney specializing in trial advocacy suggests a focus on rigorous legal analysis and potentially, a more claimant-friendly approach to evaluating petitions. Removing a voice like hers could signal a move towards a more conservative interpretation of VICP guidelines.

“The VICP is a complex system, and the ACCV’s role is to provide a balanced perspective,” explains Dr. Emily Carter, a public health lawyer specializing in vaccine policy (external link: Public Health Law Watch). “Changes in membership can subtly, or not so subtly, alter the program’s responsiveness to those seeking compensation.”

Recent Trends in Vaccine Injury Claims & Compensation

Data from the Health Resources and Services Administration (HRSA), which administers the VICP, shows a fluctuating number of petitions filed annually. In recent years, there’s been a noticeable increase in claims related to COVID-19 vaccines, though the program’s handling of these claims has been particularly scrutinized. (external link: HRSA VICP Website).

Did you know? The VICP has compensated over $4.5 billion to individuals and families since its inception, demonstrating the program’s significant financial impact.

The rise in claims, coupled with ongoing debates about vaccine mandates and potential adverse events, has placed the VICP under increased pressure. Any perceived shift in the ACCV’s composition could exacerbate existing tensions.

Potential Future Trends: What to Watch For

  • Increased Scrutiny of Claims: A more conservative ACCV could lead to stricter evaluation criteria for petitions, potentially resulting in fewer claims being approved.
  • Changes to VICP Guidelines: The HHS Secretary, influenced by the ACCV’s recommendations, could revise the program’s guidelines, altering the types of injuries covered or the evidentiary standards required.
  • Legal Challenges: Any significant changes to the VICP are likely to face legal challenges from advocacy groups representing individuals injured by vaccines.
  • Decreased Public Trust: If the program is perceived as becoming less accessible or fair, public trust in vaccines could erode, potentially impacting vaccination rates.

The Broader Context: Vaccine Hesitancy and Misinformation

These developments occur against a backdrop of growing vaccine hesitancy and the proliferation of misinformation. The COVID-19 pandemic amplified these trends, with false claims about vaccine safety circulating widely online. A robust and transparent VICP is essential for countering these narratives and maintaining public confidence in vaccination programs.

Pro Tip: Always consult with a qualified healthcare professional for accurate information about vaccines and potential side effects. Rely on credible sources like the CDC and WHO (external link: World Health Organization).

FAQ: Vaccine Injury Compensation

  • What is the VICP? The National Vaccine Injury Compensation Program is a no-fault system for compensating individuals who have been injured by vaccines.
  • How do I file a claim? You can find information about filing a claim on the HRSA website (HRSA VICP Website).
  • What types of injuries are covered? The VICP covers a specific list of injuries that have been linked to vaccines.
  • Is there a time limit for filing a claim? Yes, there are strict deadlines for filing a claim.

The removal of Veronica McNally from the ACCV is a concerning development that warrants close attention. It’s a reminder that the systems designed to protect public health and compensate those harmed by vaccines are not static, and are subject to political and ideological influences. The coming months will be crucial in determining whether this change signals a broader shift in the federal government’s approach to vaccine injury compensation.

Reader Question: What role do patient advocacy groups play in the VICP process?

Want to learn more about vaccine safety and policy? Explore our archive of articles on vaccine-related topics.

0 comments
0 FacebookTwitterPinterestEmail
Health

Judge Orders HHS to Restore $12M in Funding to Pediatricians’ Group

by Chief Editor
written by Chief Editor

Federal Court Sides with Pediatricians: A Sign of Battles to Come Over Public Health?

A federal judge’s recent decision to restore $12 million in funding to the American Academy of Pediatrics (AAP) isn’t just a win for the organization; it’s a potential bellwether for future clashes between federal agencies and groups advocating for specific public health policies. The ruling, which found likely “retaliatory motive” from the Department of Health and Human Services (HHS), highlights a growing tension over the role of scientific organizations in shaping public discourse.

The Core of the Dispute: Retaliation or Reprioritization?

The HHS claimed the grant terminations in December stemmed from a shift in departmental priorities. However, Judge Howell’s ruling suggests a different narrative: that the cuts were a direct response to the AAP’s public opposition to Trump administration policies, particularly regarding vaccines and gender-affirming care. This distinction is crucial. If proven, it sets a dangerous precedent, potentially chilling open debate within the public health sphere.

The terminated grants supported vital programs, including infant mortality prevention, rural pediatric care, and mental health services for adolescents. Losing this funding could have had a tangible impact on vulnerable populations. For example, rural communities often rely heavily on these grants to provide specialized pediatric care, and disruptions can lead to poorer health outcomes. A 2023 report by the National Rural Health Association showed that rural hospitals are disproportionately affected by funding cuts, exacerbating existing healthcare disparities.

RFK Jr.’s HHS and the Shifting Landscape of Vaccine Policy

The current situation is further complicated by the leadership of Health Secretary Robert F. Kennedy Jr., a long-time critic of vaccines. His appointment has already triggered significant changes in childhood vaccine recommendations, with the CDC recently proposing a scaled-back schedule. This has sparked considerable debate within the medical community, with organizations like the AAP issuing their own, diverging recommendations.

Did you know? The AAP’s decision to release its own vaccine recommendations is highly unusual, demonstrating the level of concern within the pediatric community regarding the potential consequences of the proposed changes.

This isn’t simply a disagreement over scientific data; it’s a clash of ideologies. The AAP’s stance reflects a commitment to evidence-based medicine and the established safety and efficacy of vaccines, while Kennedy Jr.’s approach is rooted in skepticism and a focus on potential risks. This fundamental difference is likely to fuel further conflict.

Beyond Vaccines: Gender-Affirming Care and the Doctor-Patient Relationship

The dispute extends beyond vaccines to encompass gender-affirming care. The AAP supports access to this care and has criticized HHS policies that it believes infringe upon the doctor-patient relationship. This is another area where the administration’s stance diverges sharply from mainstream medical consensus. Recent legislative efforts in several states to restrict access to gender-affirming care for minors have further intensified this debate.

Future Trends: Increased Scrutiny and Potential Legal Battles

This case signals several potential future trends:

  • Increased Scrutiny of Grant Funding: Expect greater scrutiny of grant allocations, particularly those supporting organizations that publicly challenge government policies.
  • More Legal Challenges: We can anticipate more legal battles as organizations seek to protect their funding and their ability to advocate for their positions.
  • Polarization of Public Health Debates: The already polarized landscape of public health debates is likely to become even more fractured, with increased distrust in government agencies and scientific institutions.
  • Focus on “Retaliation” Claims: The legal argument of “retaliation” will likely be used more frequently in disputes between the government and advocacy groups.

Pro Tip: Organizations should proactively document their advocacy efforts and any communications with government agencies to build a strong defense against potential retaliation claims.

The Broader Implications for Scientific Integrity

The AAP case raises fundamental questions about scientific integrity and the role of government in regulating public health discourse. If agencies can selectively punish organizations for expressing dissenting opinions, it could stifle innovation and undermine public trust in science. The long-term consequences could be devastating, leading to poorer health outcomes and a less informed public.

Frequently Asked Questions

  • What does this ruling mean for the AAP? It means the AAP will receive approximately $12 million in restored funding, allowing them to continue vital public health programs.
  • Could this happen to other organizations? Yes, it’s possible. This case sets a precedent that could be used in future disputes between the government and advocacy groups.
  • What is “retaliatory motive”? It refers to the idea that the government took action (cutting funding) specifically to punish an organization for expressing views that differed from its own.
  • What is the role of the AAP? The AAP is a professional organization of pediatricians dedicated to the health and well-being of infants, children, adolescents, and young adults.

This case is far from over. While the preliminary injunction is a significant victory for the AAP, the lawsuit will continue, and the ultimate outcome remains uncertain. However, one thing is clear: the battle over public health policy is intensifying, and the stakes are higher than ever.

Want to learn more? Explore our articles on vaccine policy and public health for deeper insights.

Share your thoughts on this developing story in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

Missed early vaccines tied to parents later skipping measles shots

by Chief Editor
written by Chief Editor

The Fading Shield: Why Early Vaccine Delays Threaten a Measles Comeback

The recent surge in measles cases – exceeding 2,000 in the US alone – isn’t a random spike. A new study published in JAMA Network Open reveals a disturbing trend: delays in initial vaccinations at 2 months dramatically increase the likelihood of children missing crucial doses later, particularly the measles, mumps, and rubella (MMR) vaccine. This isn’t just about scheduling conflicts; it’s a sign of deepening vaccine hesitancy and a potential unraveling of decades of public health progress.

The Two-Month Window: A Critical Turning Point

The study, analyzing data from over 322,000 children, found that babies who didn’t receive their initial vaccinations on time were over seven times more likely to be unvaccinated against measles by age two. This highlights the critical importance of the 2-month visit. It’s not simply about protecting against those initial diseases; it establishes a pattern of preventative care. As Nina Masters, the study’s lead epidemiologist, explains, “Hesitancy is really starting early and has a long arc.”

This finding aligns with previous research demonstrating that past vaccine receipt is a strong predictor of future vaccination. Noel Brewer, a health behavior professor at UNC, emphasizes the power of a doctor’s recommendation. “The most promising avenue for intervention is a doctor’s recommendation.” But the window to deliver that recommendation effectively is narrowing.

The Pandemic’s Lingering Shadow and Rising Distrust

The decline in vaccination rates isn’t happening in a vacuum. The COVID-19 pandemic fueled distrust in public health institutions and sparked resentment over containment measures. This erosion of trust has spilled over into childhood vaccinations, creating a fertile ground for misinformation and hesitancy. The study observed a three percentage point drop in on-time MMR vaccinations between 2021 and 2024 – a “substantial drop” according to Masters.

Did you know? The US is at risk of losing its measles elimination status, a designation achieved in 2000. Continued outbreaks could reverse decades of progress.

Beyond Delays: A Growing Number of Unvaccinated Children

What’s particularly concerning isn’t just that more children are delaying vaccinations; it’s that more are forgoing them altogether. While the percentage of children receiving the MMR vaccine late remained relatively stable, the number not vaccinated by age two rose from 5.3% in 2020 to 7.7% in 2024. This suggests a shift from simple procrastination to outright refusal.

The Impact of Policy Changes and Shifting Recommendations

The situation is further complicated by recent policy changes. The appointment of Robert F. Kennedy Jr. as a health official led to the dismissal of the CDC’s vaccine advisory panel and its replacement with individuals skeptical of vaccine safety. This culminated in a controversial decision to alter the hepatitis B vaccination schedule, recommending it only for babies at risk, rather than universally at birth.

Experts worry these changes will further erode public confidence and contribute to lower vaccination rates. Masters and her team are already investigating the potential implications of the hepatitis B policy shift.

The Challenge for Pediatricians: Building Trust Quickly

Pediatricians are on the front lines of this battle. The American Academy of Pediatrics recommends frequent early visits, providing opportunities to build trust and educate parents. However, the 2-month visit often involves multiple vaccinations, leaving limited time for meaningful conversations.

Pro Tip: Pediatricians can proactively address vaccine concerns during prenatal visits or even before the 2-month appointment, establishing a foundation of trust and open communication.

Furthermore, many families don’t adhere to the recommended schedule, and a significant portion lack a consistent medical home. This makes reaching vulnerable populations even more challenging.

Looking Ahead: What Can Be Done?

Reversing this trend requires a multi-pronged approach. Strengthening trust in healthcare providers, combating misinformation, and ensuring equitable access to care are crucial. Public health campaigns need to be targeted and tailored to address specific concerns within different communities.

The data underscores the need for proactive intervention. Waiting until the 2-month visit may be too late. Early engagement, clear communication, and a strong doctor’s recommendation are essential to protect children and prevent a resurgence of preventable diseases.

FAQ: Addressing Common Concerns

  • Q: Is it okay to delay vaccinations if my baby is healthy?
    A: No. Delaying vaccinations increases the risk of your child contracting preventable diseases and can disrupt the vaccination schedule, making it harder to achieve full protection.
  • Q: Where can I find reliable information about vaccines?
    A: The CDC (https://www.cdc.gov/vaccines/index.html) and the Immunization Action Coalition (https://www.immunize.org/) are excellent sources of evidence-based information.
  • Q: What if I have concerns about vaccine side effects?
    A: Discuss your concerns with your pediatrician. Serious side effects are rare, and the benefits of vaccination far outweigh the risks.

Reader Question: “My friend told me vaccines cause autism. Is this true?”

A: This claim has been thoroughly debunked by numerous scientific studies. There is no link between vaccines and autism. The original study that sparked this fear was retracted due to fraudulent data.

Want to learn more? Explore our articles on vaccine safety and the importance of herd immunity.

Share your thoughts on this important issue in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

Delayed Baby Vaccines Linked to Lower MMR Rates Amid Rising Measles Cases

by Chief Editor
written by Chief Editor

The Fading Window for Childhood Immunity: Why Early Vaccine Delays Matter More Than Ever

A concerning trend is emerging in childhood vaccination rates: a delay in the first round of vaccines at 2 months significantly increases the likelihood a child will fall behind on crucial immunizations, including protection against measles, mumps, and rubella. New research, published in JAMA Network Open, underscores the critical importance of those initial pediatric visits and the potential for long-term consequences when they’re missed.

The 2-Month Mark: A Pivotal Moment

The study, analyzing data from over 322,000 children, revealed that babies who didn’t receive their initial vaccinations on schedule were over seven times more likely to not receive the MMR vaccine by age 2. This isn’t simply a matter of logistical delays; it points to a deeper issue of vaccine hesitancy taking root early and persisting over time. Epidemiologist Nina Masters, lead author of the study, emphasizes that this early hesitation creates a “long arc” of potential vulnerability.

This finding is particularly alarming given the recent surge in measles cases. As of December 30, 2025, the CDC reported 2,065 confirmed cases – the highest number in over three decades. The potential loss of measles elimination status in the U.S. is a very real threat, with outbreaks like the one originating in West Texas fueling concerns.

The Pandemic’s Lingering Impact & Eroding Trust

While delayed vaccinations aren’t a new phenomenon, the study highlights a noticeable dip in on-time vaccinations beginning around 2021. Experts attribute this to a confluence of factors stemming from the COVID-19 pandemic: increased distrust in public health authorities, resentment over containment measures, and disruptions to routine healthcare access. This erosion of trust extends beyond COVID-19 vaccines, impacting adherence to the established childhood immunization schedule.

Did you know? A strong predictor of future vaccination adherence is having received *any* vaccine in the past. This reinforces the importance of establishing a vaccination history early in a child’s life.

Beyond Delays: A Growing Number of Unvaccinated Children

The data reveals a shift in the pattern of vaccine hesitancy. It’s not just that more parents are *delaying* vaccinations; a growing number are choosing not to vaccinate their children at all. The percentage of children who hadn’t received a first MMR dose by age 2 rose from 5.3% in 2020 to 7.7% in 2024 – a substantial increase in a relatively short period.

The Pediatrician’s Role: Building Trust Early

The study underscores the crucial role pediatricians play in promoting vaccination. A doctor’s recommendation remains one of the most powerful influences on a parent’s decision. However, the 2-month visit often presents a challenge: limited time to build trust and address concerns with new parents amidst a flurry of initial vaccinations.

Experts suggest pediatricians proactively engage parents about the importance of vaccination *before* the 2-month appointment. Frequent early visits, as recommended by the American Academy of Pediatrics (AAP), provide opportunities to establish rapport and address potential hesitancy.

Pro Tip: Pediatricians can utilize resources from the CDC and AAP to prepare for vaccine conversations and address common parental concerns effectively.

Challenges to Coverage: Access and Consistency

The study also revealed that less than half of the babies studied followed the AAP’s recommended early visit schedule. This highlights disparities in access to care, particularly for families without insurance or a consistent medical home. These gaps in access exacerbate the problem of delayed and missed vaccinations.

The Impact of Policy Shifts & Future Concerns

Recent changes in vaccination policy, particularly those implemented under the current administration, add another layer of complexity. The CDC’s recent decision to alter the hepatitis B vaccination schedule – recommending it only for babies at high risk – raises concerns about potential further declines in vaccination rates. Experts are closely monitoring the implications of these changes.

Looking Ahead: Potential Future Trends

Several trends are likely to shape the future of childhood vaccination:

  • Increased Polarization: The debate surrounding vaccines is likely to become more polarized, fueled by misinformation and political agendas.
  • Targeted Interventions: Public health efforts will likely focus on targeted interventions to reach specific communities with low vaccination rates.
  • Technological Solutions: Digital tools, such as reminder systems and educational resources, may play a greater role in promoting vaccination.
  • Focus on Early Engagement: Pediatricians will increasingly prioritize early engagement with parents to build trust and address concerns proactively.
  • Impact of Political Appointments: The influence of political appointees on public health policy will continue to be a significant factor.

FAQ: Common Questions About Childhood Vaccination

  • Q: What is the recommended vaccination schedule?
    A: The CDC provides a detailed, age-appropriate vaccination schedule available at https://www.cdc.gov/vaccines/imz-schedules/child-easyread.html.
  • Q: What if my child misses a vaccination?
    A: Talk to your pediatrician about catching up on missed vaccinations.
  • Q: Are vaccines safe?
    A: Vaccines are rigorously tested and monitored for safety. Serious side effects are rare.
  • Q: Where can I find more information about vaccines?
    A: The CDC (https://www.cdc.gov/vaccines/) and the AAP (https://www.aap.org/) are excellent resources.

The challenge of maintaining high vaccination rates requires a multi-faceted approach, encompassing proactive communication, increased access to care, and a renewed commitment to building trust in public health. The future of childhood immunity depends on it.

Want to learn more? Explore our other articles on public health and vaccine safety.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts